180 related articles for article (PubMed ID: 19574558)
1. Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia.
Wu J; Peng L; McMahon GA; Lawrence DA; Fay WP
Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1565-70. PubMed ID: 19574558
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor-1 regulates the vascular expression of vitronectin.
Luo M; Ji Y; Luo Y; Li R; Fay WP; Wu J
J Thromb Haemost; 2017 Dec; 15(12):2451-2460. PubMed ID: 29028290
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor-1 and vitronectin expression level and stoichiometry regulate vascular smooth muscle cell migration through physiological collagen matrices.
Garg N; Goyal N; Strawn TL; Wu J; Mann KM; Lawrence DA; Fay WP
J Thromb Haemost; 2010 Aug; 8(8):1847-54. PubMed ID: 20492459
[TBL] [Abstract][Full Text] [Related]
4. Endogenous vitronectin and plasminogen activator inhibitor-1 promote neointima formation in murine carotid arteries.
Peng L; Bhatia N; Parker AC; Zhu Y; Fay WP
Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):934-9. PubMed ID: 12067901
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor 1 and vitronectin protect against stenosis in a murine carotid artery ligation model.
de Waard V; Arkenbout EK; Carmeliet P; Lindner V; Pannekoek H
Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):1978-83. PubMed ID: 12482822
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.
Ji Y; Weng Z; Fish P; Goyal N; Luo M; Myears SP; Strawn TL; Chandrasekar B; Wu J; Fay WP
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2167-2175. PubMed ID: 27659097
[TBL] [Abstract][Full Text] [Related]
7. Cilostazol inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor expression in artery wall and neointimal region after vascular injury.
Lee KM; Lee HJ; Kim MK; Kim HS; Jung GS; Hur SH; Kim HT; Cho WH; Kim JG; Kim BW; Lim JO; Choi HS; Lee KU; Park KG; Lee IK
Atherosclerosis; 2009 Dec; 207(2):391-8. PubMed ID: 19586629
[TBL] [Abstract][Full Text] [Related]
8. Multifaceted role of plasminogen activator inhibitor-1 in regulating early remodeling of vein bypass grafts.
Ji Y; Strawn TL; Grunz EA; Stevenson MJ; Lohman AW; Lawrence DA; Fay WP
Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1781-7. PubMed ID: 21571686
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice.
Konstantinides S; Schäfer K; Thinnes T; Loskutoff DJ
Circulation; 2001 Jan; 103(4):576-83. PubMed ID: 11157725
[TBL] [Abstract][Full Text] [Related]
10. Recombinant soluble apyrase APT102 inhibits thrombosis and intimal hyperplasia in vein grafts without adversely affecting hemostasis or re-endothelialization.
Ji Y; Adeola O; Strawn TL; Jeong SS; Chen R; Fay WP
J Thromb Haemost; 2017 Apr; 15(4):814-825. PubMed ID: 28079982
[TBL] [Abstract][Full Text] [Related]
11. A small molecule PAI-1 functional inhibitor attenuates neointimal hyperplasia and vascular smooth muscle cell survival by promoting PAI-1 cleavage.
Simone TM; Higgins SP; Archambeault J; Higgins CE; Ginnan RG; Singer H; Higgins PJ
Cell Signal; 2015 May; 27(5):923-33. PubMed ID: 25617690
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice.
Zhu Y; Farrehi PM; Fay WP
Circulation; 2001 Jun; 103(25):3105-10. PubMed ID: 11425776
[TBL] [Abstract][Full Text] [Related]
13. Salusin-β Promotes Vascular Smooth Muscle Cell Migration and Intimal Hyperplasia After Vascular Injury via ROS/NFκB/MMP-9 Pathway.
Sun HJ; Zhao MX; Ren XS; Liu TY; Chen Q; Li YH; Kang YM; Wang JJ; Zhu GQ
Antioxid Redox Signal; 2016 Jun; 24(18):1045-57. PubMed ID: 26952533
[TBL] [Abstract][Full Text] [Related]
14. Total Panax notoginseng saponin inhibits vascular smooth muscle cell proliferation and migration and intimal hyperplasia by regulating WTAP/p16 signals via m
Zhu B; Gong Y; Shen L; Li J; Han J; Song B; Hu L; Wang Q; Wang Z
Biomed Pharmacother; 2020 Apr; 124():109935. PubMed ID: 31986407
[TBL] [Abstract][Full Text] [Related]
15. Wound-induced migration of MDA-MB-435 and SKOV-3 cancer cells is regulated by plasminogen activator inhibitor-1.
Whitley BR; Church FC
Int J Oncol; 2005 Sep; 27(3):749-57. PubMed ID: 16077925
[TBL] [Abstract][Full Text] [Related]
16. Salvianolic acid B inhibits Ang II-induced VSMC proliferation in vitro and intimal hyperplasia in vivo by downregulating miR-146a expression.
Zhao XS; Zheng B; Wen Y; Sun Y; Wen JK; Zhang XH
Phytomedicine; 2019 May; 58():152754. PubMed ID: 31009837
[TBL] [Abstract][Full Text] [Related]
17. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression.
Zhan Y; Kim S; Izumi Y; Izumiya Y; Nakao T; Miyazaki H; Iwao H
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):795-801. PubMed ID: 12637337
[TBL] [Abstract][Full Text] [Related]
18. The effects of pharmacological PAI-1 inhibition on thrombus formation and neointima formation after arterial injury.
Suzuki J; Ogawa M; Muto S; Yamaguchi Y; Itai A; Isobe M
Expert Opin Ther Targets; 2008 Jul; 12(7):783-94. PubMed ID: 18554148
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human interleukin-10 inhibits proliferation of vascular smooth muscle cells stimulated by advanced glycation end products and neointima hyperplasia after carotid injury in the rat.
Ouyang P; Peng LS; Yang H; Peng WL; Wu WY; Xu AL
Sheng Li Xue Bao; 2003 Apr; 55(2):128-34. PubMed ID: 12715099
[TBL] [Abstract][Full Text] [Related]
20. Naringenin inhibits angiotensin II-induced vascular smooth muscle cells proliferation and migration and decreases neointimal hyperplasia in balloon injured rat carotid arteries through suppressing oxidative stress.
Xu C; Chen J; Zhang J; Hu X; Zhou X; Lu Z; Jiang H
Biol Pharm Bull; 2013; 36(10):1549-55. PubMed ID: 23912743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]